LifeVac is FDA authorized. On March 4, 2026, the FDA granted LifeVac marketing authorization through the De Novo classification pathway, making it the only anti-choking suction device legally authorized for sale in the United States. That said, the distinction between “approved” and “authorized” matters, and the FDA has issued specific safety guidance about how and when to use devices like this.
What “FDA Authorized” Actually Means
The FDA uses different regulatory pathways for different types of products. Drugs go through an “approval” process. Medical devices, on the other hand, are typically “cleared” or “authorized.” LifeVac went through what’s called the De Novo pathway (classification number DEN250012), which is reserved for novel, low-to-moderate risk devices that don’t have an existing category to be compared against. This is a legitimate form of FDA authorization, not a lesser standard. It means the FDA reviewed the device’s safety and effectiveness data and decided it could be legally marketed.
Before this authorization, LifeVac was sold without formal FDA marketing authorization, a situation that applied to all anti-choking suction devices on the market. In October 2025, the FDA issued an import alert listing multiple suction-based anti-choking devices that lacked authorization. LifeVac is currently the only device in this category that has cleared the FDA’s regulatory bar.
How LifeVac Works
LifeVac creates suction over a person’s mouth and nose to pull a lodged object out of the airway. You push down on the plunger to expel air, place the mask over the choking person’s face, then pull the plunger back up to generate negative pressure. Testing on the certified device shows it generates about 154 mmHg of peak suction pressure. For context, counterfeit versions of the device tested in a published comparison produced only about 62 mmHg, roughly 60% less suction, which is one reason the FDA has cracked down on unauthorized copies.
The device comes with two mask sizes. The manufacturer recommends the pediatric mask for children 22 pounds and up, though LifeVac claims it has been used successfully on infants below that weight. There’s no published maximum weight for the pediatric mask or minimum weight for the adult mask, which Consumer Reports has flagged as a gap in the product’s guidance.
What the Research Shows
A systematic review and meta-analysis pooling six studies with 789 total subjects found LifeVac had a 97.79% success rate for clearing airway obstructions, the highest among the devices and techniques studied. The Dechoker, a competitor, came in at 94.82%, while the traditional Heimlich maneuver showed a 71.11% success rate. On average, about two attempts with the device were needed to clear the obstruction. Studies using human subjects showed slightly better results than those using manikins.
Those numbers look impressive, but earlier independent reviews have pointed out significant limitations in the available research. A systematic review led by Dunne et al. identified a high risk of bias across anti-choking device studies, including industry involvement in the research and reporting bias. The certainty of evidence was rated low despite the high success rates. Several of the key studies are case reports or case series rather than randomized controlled trials, which means the real-world effectiveness could differ from what’s been published.
FDA Safety Warnings to Know About
Even with LifeVac now authorized, the FDA’s official position is clear: standard choking rescue protocols come first. The agency specifically warns that using an anti-choking device before trying established techniques (back blows and abdominal thrusts, as recommended by the American Red Cross and American Heart Association) could delay critical life-saving action. Neither the Red Cross nor the AHA has incorporated suction devices into their standard choking rescue guidelines.
The FDA has also received reports of problems with anti-choking devices generally, including failure to resolve choking due to insufficient suction, bruising around the face, lips, and mouth, and scratches in the back of the throat. There’s also a practical timing concern: removing the device from its packaging and assembling it takes time that could be spent performing abdominal thrusts or back blows, techniques that require no equipment and can begin immediately.
How It Compares to Other Devices
LifeVac’s main competitor, the Dechoker, does not have FDA marketing authorization. The FDA issued a warning letter to DeChoker LLC in May 2021 for failing to comply with manufacturing quality requirements, and the company remains unauthorized. Other suction-based anti-choking devices were included in the October 2025 import alert. As of now, if you’re buying an anti-choking suction device in the U.S., LifeVac is the only one with legal FDA authorization.
That regulatory distinction doesn’t automatically make it the best tool for every choking emergency. The Heimlich maneuver’s lower success rate in the meta-analysis (71%) partly reflects the difficulty of performing it correctly under pressure, but it has decades of real-world validation and can be started in seconds with no equipment. LifeVac is best understood as a backup option, something to reach for when standard techniques have failed, not a replacement for learning basic choking first aid.